Northern Trust’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
175,767
-22,854
-12% -$2.08M ﹤0.01% 2002
2025
Q4
$25.8M Sell
198,621
-7,840
-4% -$1.08M ﹤0.01% 1504
2025
Q3
$22.2M Sell
206,461
-8,523
-4% -$929K ﹤0.01% 1617
2025
Q2
$19.8M Buy
214,984
+29,795
+16% +$2.34M ﹤0.01% 1648
2025
Q1
$16.4M Buy
185,189
+5,538
+3% +$480K ﹤0.01% 1749
2024
Q4
$13.8M Buy
179,651
+29,608
+20% +$2.07M ﹤0.01% 1937
2024
Q3
$6.37M Buy
150,043
+86,421
+136% +$2.92M ﹤0.01% 2343
2024
Q2
$1.66M Buy
63,622
+5,229
+9% +$99.1K ﹤0.01% 3001
2024
Q1
$533K Sell
58,393
-1,019
-2% -$6.12K ﹤0.01% 3538
2023
Q4
$163K Buy
59,412
+26,680
+82% +$62K ﹤0.01% 3964
2023
Q3
$119K Hold
32,732
﹤0.01% 3968
2023
Q2
$195K Sell
32,732
-61,635
-65% -$488K ﹤0.01% 3842
2023
Q1
$1.14M Buy
94,367
+40,257
+74% +$537K ﹤0.01% 3180
2022
Q4
$471K Buy
54,110
+7,701
+17% +$170K ﹤0.01% 3528
2022
Q3
$1.34M Sell
46,409
-233
-0.5% -$10.7K ﹤0.01% 3197
2022
Q2
$1.94M Buy
46,642
+38,993
+510% +$2.65M ﹤0.01% 3086
2022
Q1
$775K Sell
7,649
-211
-3% -$23.5K ﹤0.01% 3547
2021
Q4
$1.16M Buy
7,860
+1,152
+17% +$257K ﹤0.01% 3485
2021
Q3
$1.68M Buy
+6,708
New +$2.3M ﹤0.01% 3369

Other funds holding WGS

Northern Trust's WGS Position: Q1 2026 in Review

Northern Trust reduced its GeneDx Holdings (WGS) stake by 12% in Q1 2026, selling an estimated $2.08M and leaving 175,767 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Northern Trust first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $25.8M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Northern Trust held 175,767 shares of GeneDx Holdings worth $11.3M as of Q1 2026.
  • Northern Trust sold 22,854 GeneDx Holdings shares in Q1 2026, an estimated $2.08M.
  • GeneDx Holdings made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2002 holding.
  • Northern Trust first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's GeneDx Holdings position peaked at $25.8M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.